Request a quote
All products
Active Pharmaceutical IngredientsPharmaceutical IntermediatesVeterinary APIsPharmaceutical Packaging
Quality & compliance Resources About Contact
ENESFRRU
Request a quote

Morpholine

1-Oxa-4-azacyclohexane, diethylene oximide · CAS 110-91-8

Intermediates Technical / pharmaceutical intermediate CoA per lotSDSGMP statement

A volatile secondary amine with a low flash point, so it moves as a hazardous cargo in closed drums. Purity above 99.5% is the norm; the impurity that matters is the water and the ammonia carry-over.

A heterocyclic building block. Route notes and the isomer profile are available before you commit to a trial.

Identity

Catalogue no.BP-INT-012
CAS number110-91-8
Molecular formulaC4H9NO
Molecular weight87.12 g/mol
HS code2934.99
Synonyms1-Oxa-4-azacyclohexane, diethylene oximide
Product linePharmaceutical Intermediates
CategoryHeterocyclic Building Blocks

Release specification

Catalogue standard below. For a supply agreement we release against your dossier specification; send it with the enquiry and the CoA will be built around it.

ParameterSpecification
Assay≥ 99.5%
Related substancesWater content ≤ 0.20%; any unspecified impurity ≤ 0.30%
Water content≤ 0.5% (Karl Fischer)
Heavy metals≤ 20 ppm (ICP-MS)
Flash point31 °C (closed cup)
Colour≤ 15 Hazen

Application

Intermediate for morpholine-based APIs, rubber accelerators and optical brighteners.

Packaging, storage & logistics

Standard packaging200 kg steel drum; 1000 kg IBC
Minimum order200 kg
Lead time15–25 days
Storage conditionsStore in a cool, dry, ventilated area away from oxidisers
Shipping documentsInvoice, packing list, CoA, SDS, certificate of origin; DGM/IATA declaration where applicable

Pack sizes available — pick one to prefill the enquiry

1 kg25 kg200 kg1 000 kg

Documentation provided

  • CoA per lotLot-specific, with the test methods cited
  • SDSCurrent GHS revision; destination-language version on request
  • GMP statementSite-level GMP status and the last audit date, issued per customer

Need the DMF open part, a sample CoA or an audit pack before you can qualify us? Ask on the enquiry form — we send those documents before any commercial discussion.

Request a quotation

Submitting opens your email client with these details filled in, so the enquiry reaches gm@bioranpharma.com directly. We use your details only to answer this enquiry — see privacy & data use.

Related products